DexCom's Q3 results showed disappointing 2% revenue growth and a 26% decline in operating income. Click here to read my DXCM ...
Edwards Lifesciences Corporation's market leadership and recent growth position it well. See more on EW stock and why it's ...
Jefferies analyst Matthew Taylor maintained a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...
In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price ...
incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 61,682.69 Crore) operating in Pharmaceuticals sector. Abbott India Ltd. key Products/Revenue Segments include ...
The global lateral flow assays market is poised for substantial growth, with projections indicating a surge to USD 6.9 ...
incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 152,290.03 Crore) operating in Pharmaceuticals sector. Divi's Laboratories Ltd. key Products/Revenue Segments include ...
Glucose Monitoring Devices MarketAs the global burden of diabetes continues to grow, the need for accurate and efficient ...
Though Apple doesn’t have plans to release the app, the company may eventually integrate the technology into future health ...
The Inspirational Rags-to-Riches Story of A.E. Staley" is available to stream through Amazon and Amazon Prime.
Recent market analyses reveal a promising trajectory for the global opioid analgesics market, forecasting significant growth to USD 72.0 billion by 2033, with a robust Compound Annual Growth Rate ...